
Long COVID and Digestive Symptoms: What the Research Tells Us
Research summary exploring digestive manifestations of Long COVID, including gut microbiome changes, IBS risk and potential treatment approaches.
This narrative review shows that POTS, ME/CFS and Long COVID are closely related conditions that share common biological mechanisms. The authors explain that problems with the autonomic nervous system, immune dysregulation and autoimmunity, mitochondrial dysfunction, reduced blood flow to the brain, and neuroinflammation all play a role. POTS and ME/CFS are identified as the most common forms of Long COVID, with many people experiencing significant disability. Brain imaging and immune studies suggest these symptoms are driven by physical changes in the brain and immune system, not psychological causes.
The authors argue that these conditions should be recognised as neuroimmune disorders and treated within the field of neuroimmunology. They highlight how patients have often been misdiagnosed or dismissed, delaying effective care. Reframing these illnesses as neuroimmune conditions would improve diagnosis, training, research, and access to appropriate treatments, including immunomodulatory therapies. The paper calls for a clear shift in thinking to better support people living with these long-term, disabling conditions.

Figure downloaded from the paper which can be downloaded by clicking here.

Research summary exploring digestive manifestations of Long COVID, including gut microbiome changes, IBS risk and potential treatment approaches.

Returning to work is often viewed as a major milestone in recovery. However, for many people living with Long COVID, returning to work does not necessarily mean returning to their previous level of health. This study by Su and colleagues explored the experiences of 79 adults living with Long COVID who had returned to employment. […]

Learn why the precautionary principle is fundamental to infection prevention and how its application protects healthcare workers and patients.